Clinical Trial Update: Three-Year Trial on a New Testosterone Gel [Phase 3]

View source ↗

Summary

This entry reports a three-year Phase 3 clinical trial evaluating a new testosterone gel for hypogonadism.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Hypogonadism

Drugs mentioned

• Testosterone gel (Testosterone)

Snippet

Sponsor: University Hospital Muenster | Conditions: Hypogonadism | Phase 3 | Status: UNKNOWN